Profilo
Susan Doleman is currently the Vice President-Clinical Operations at Cyteir Therapeutics, Inc. She previously worked as the Senior Director-Clinical Operations at Epizyme, Inc., a Scientist at The Children's Hospital Corp., and the Vice President-Clinical Development Operations at Replimune Group, Inc. Ms. Doleman received her undergraduate degree from Smith College.
Posizioni attive di Susan Doleman
| Società | Posizione | Inizio |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2019 |
Precedenti posizioni note di Susan Doleman
| Società | Posizione | Fine |
|---|---|---|
| EPIZYME, INC. | Direttore Tecnico/Scientifico/R&S | - |
The Children's Hospital Corp.
The Children's Hospital Corp. Hospital/Nursing ManagementHealth Services Operates pediatric hospitals | Direttore Tecnico/Scientifico/R&S | - |
| REPLIMUNE GROUP, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Susan Doleman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Smith College
Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital Corp.
The Children's Hospital Corp. Hospital/Nursing ManagementHealth Services Operates pediatric hospitals | Health Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Replimune Group, Inc.
Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company | Health Technology |
















